Convalescent anti-SARS-CoV-2 plasma for the treatment of patients with COVID-19: a retrospective study RESCOVID-19
Virology Journal · 2024
DOI: 10.1186/s12985-024-02475-y ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Virology Journal, 2024. Verfasst von Miloš Bohoněk und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Blood Transfusion, Military University Hospital Prague, Prague, Czech Republic. Hauptthemen laut MEDLINE: Immunization, Passive, COVID-19, COVID-19 Serotherapy, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministerstvo Obrany České Republiky.
Abstract (Originalsprache)
PURPOSE: Convalescent plasma (CP) collected from people who recovered from COVID-19 became a rapidly available treatment modality in numerous countries, including the Czech Republic. The aims of our study were to evaluate the effectiveness and safety of CP in the treatment of COVID-19. METHODS: This retrospective observational study involved six Czech hospitals. This study enrolled patients with and without CP treatment who were hospitalized between April 2020 and April 2021. Propensity score matching and logistic regression analysis were performed to evaluate the influence of CP administration and its timing on the in-hospital survival of COVID-19 patients. RESULTS: A total of 1,498 patients were enrolled in the study; 406 (27%) were administered CP, and 1,092 (73%) were not treated with CP. The propensity score-matched control group consisted of 1,218 subjects. The survival of patients treated with CP was 79%, while that of patients in the matched control group was 62% (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Blood Transfusion, Military University Hospital Prague, Prague, Czech Republic.
- Faculty of Biomedical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
- Department of Anesthesiology and Intensive Care, Faculty of Medicine, University of Ostrava and University Hospital Ostrava, Ostrava, Czech Republic.
- Institute of Physiology and Pathological Physiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- Department of Infectious Diseases, Faculty of Medicine, University of Ostrava and University Hospital Ostrava, Ostrava, Czech Republic.
- Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Förderung
- Ministerstvo Obrany České Republiky
Zitieren
APA
Bohoněk, M., Máca, J., Sagan, J., Řezáč, D., Fridrich, V., Burantová, A., Kutáč, D., Vabroušek, P., Kubů, J., Chrdle, A., Volfová, K., Blahutová, Š., Rychlík, I., Vonášková, K., Majerčin, R., Králová, R., Štěpánek, P., & Holub, M. (2024). Convalescent anti-SARS-CoV-2 plasma for the treatment of patients with COVID-19: a retrospective study RESCOVID-19. Virology Journal. https://doi.org/10.1186/s12985-024-02475-y
Vancouver
Bohoněk M, Máca J, Sagan J, Řezáč D, Fridrich V, Burantová A, et al. Convalescent anti-SARS-CoV-2 plasma for the treatment of patients with COVID-19: a retrospective study RESCOVID-19. Virology Journal. 2024. doi:10.1186/s12985-024-02475-y
BibTeX
@article{Bohonk2024,
author = {Bohoněk, Miloš and Máca, Jan and Sagan, Jiří and Řezáč, David and Fridrich, Viktor and Burantová, Anna and Kutáč, Dominik and Vabroušek, Pavel and Kubů, Jan and Chrdle, Aleš and Volfová, Kateřina and Blahutová, Šárka and Rychlík, Ivan and Vonášková, Kateřina and Majerčin, Radek and Králová, Radka and Štěpánek, Petr and Holub, Michal},
title = {Convalescent anti-SARS-CoV-2 plasma for the treatment of patients with COVID-19: a retrospective study RESCOVID-19},
journal = {Virology Journal},
year = {2024},
doi = {10.1186/s12985-024-02475-y}
}
EUVIMED